Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
87.44 BRL | +8.35% | +0.02% | +39.97% |
05:28pm | NOVO NORDISK : JP Morgan reiterates its Buy rating | ZD |
03:19pm | Novo Nordisk's Ozempic Reduces Kidney Disease, Death Risk According to Study of Patients With Type 2 Diabetes | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- NOVO B Stock
- N1VO34 Stock
- Revisions Novo Nordisk A/S